PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

drospirenone/ethinyl estradiol vs ethinyl estradiol/norgestimate

Side-by-side comparison of drospirenone/ethinyl estradiol and ethinyl estradiol/norgestimate Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
drospirenone/ethinyl estradiol Combined Oral Contraceptive
ethinyl estradiol/norgestimate Combined Oral Contraceptive
Type
drospirenone/ethinyl estradiol Prescription
ethinyl estradiol/norgestimate Prescription
Summary
drospirenone/ethinyl estradiol

This medicine contains drospirenone and ethinyl estradiol, which are hormones that prevent pregnancy. It also contains folate to help raise folate levels.

ethinyl estradiol/norgestimate

Iclevia is a birth control pill. It contains two hormones, levonorgestrel and ethinyl estradiol, to prevent pregnancy.

What It Treats
drospirenone/ethinyl estradiol

This medicine can prevent pregnancy. It can also treat symptoms of premenstrual dysphoric disorder (PMDD) if you also want birth control. This medicine can also treat moderate acne in women at least 14 years old who also want birth control.

ethinyl estradiol/norgestimate

Iclevia is used by women who can get pregnant to prevent pregnancy. It contains two hormones, a progestin and an estrogen. These hormones work together to prevent ovulation and change the lining of the uterus.

How It Works
drospirenone/ethinyl estradiol

This medicine prevents pregnancy by stopping ovulation (the release of an egg from the ovary). It also changes the lining of the uterus, making it harder for a fertilized egg to implant. The folate helps increase folate levels in the body.

ethinyl estradiol/norgestimate

Iclevia contains two hormones: levonorgestrel and ethinyl estradiol. These hormones prevent ovulation (the release of an egg from the ovary). They also change the lining of the uterus, making it harder for a fertilized egg to implant.

Common Side Effects
drospirenone/ethinyl estradiol
  • Headache or migraine
  • Irregular periods
  • Nausea or vomiting
  • Breast pain or tenderness
ethinyl estradiol/norgestimate
  • Headache
  • Heavier menstrual bleeding
  • Nausea
  • Painful periods
  • Acne
FAERS Reports
drospirenone/ethinyl estradiol
  • Pain 13,037
  • Injury 10,860
  • Blood clot in the lungs 9,316
  • Blood clot in a deep vein 8,390
  • Anxiety 6,996
ethinyl estradiol/norgestimate

No adverse event reports.

Serious Warnings
drospirenone/ethinyl estradiol

Cigarette smoking increases your risk of serious heart problems when using birth control pills. This risk is higher if you are over 35 and smoke. Women over 35 who smoke should not use this medicine.

ethinyl estradiol/norgestimate

Cigarette smoking increases your risk of serious heart problems from birth control pills. This risk is higher if you are over 35 and smoke more cigarettes. If you are over 35 and smoke, you should not take Iclevia.

Pregnancy
drospirenone/ethinyl estradiol

Do not use this medicine if you are pregnant. This medicine can reduce milk production while breastfeeding. If possible, use other birth control methods until you stop breastfeeding.

ethinyl estradiol/norgestimate

Do not use Iclevia if you are pregnant. Iclevia can reduce milk production while breastfeeding, so another form of birth control is recommended. Talk to your doctor about the best option for you.

Also Compare — Nearby Drugs

How to Read This drospirenone/ethinyl estradiol vs ethinyl estradiol/norgestimate Comparison

drospirenone/ethinyl estradiol is classified in the Combined Oral Contraceptive drug class, while ethinyl estradiol/norgestimate sits within the Combined Oral Contraceptive class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, drospirenone/ethinyl estradiol has 48,599 submissions while ethinyl estradiol/norgestimate has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between drospirenone/ethinyl estradiol and ethinyl estradiol/norgestimate — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.